10x Genomics Begins Commercial Shipments Of Its Transcriptome Analysis Tool Atera

10x Genomics has commenced commercial shipments of its transcriptome analysis tool, Atera, which is now being utilized by researchers globally across various fields, including oncology and neurodegenerative diseases. The company reported that booked orders for Atera have surpassed the initial expectation of 40 instruments to be shipped by 2026, indicating strong demand. The platform is expected to support a wide range of research applications, including cell and tissue atlasing and biomarker research.